News

FluoSphera secures $1 million pre-seed investment

FluoSphera, an UNIGE biotech spin-off specialising in predicting the effects of molecules through animal-free microphysiological systems, has completed a world-class acceleration program in New York and attracted further renowned investors. The spin-off has now secured a pre-seed investment round of $1 million. The US accelerator IndieBio New York which is part of SOSV, Swiss-based Mountain Labs, and EFI Lake Geneva Ventures participated in this round along with private business angels. FluoSphera will develop its unique technology platform to provide the pharma industry with unprecedented solutions to improve drug discovery.

See startupticker.ch press release here.

 

March 9, 2023
  News